Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05665244 · ClinicalTrials.gov registry record
Laryngeal Cryotherapy for Refractory Neurogenic Cough
A clinical trial of Upper-Airway Cough Syndrome, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT05665244 is a study of Upper-Airway Cough Syndrome that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05665244, a study of Upper-Airway Cough Syndrome, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the safety and efficacy of upper aerodigestive tract cryotherapy treatment in patients with refractory neurogenic cough in a prospective pilot study with a validated patient reported outcome measure
Conditions Studied
Interventions
- PROCEDURE Laryngeal cryotherapy
- DEVICE Cryoprobe
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-12-26 |
| Est. Completion | 2027-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05665244
The ClinicalTrials.gov registry entry for NCT05665244 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Upper-Airway Cough Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Laryngeal cryotherapy is the first listed.
NCT05665244 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05665244 about?
NCT05665244 is a clinical study titled "Laryngeal Cryotherapy for Refractory Neurogenic Cough". This study aims to evaluate the safety and efficacy of upper aerodigestive tract cryotherapy treatment in patients with refractory neurogenic cough in a prospective pilot study with a validated patient reported outcome measure
What is the current status of trial NCT05665244?
This trial is currently recruiting. The enrollment target is 28 participants. The study started on 2022-12-26. Estimated completion is 2027-02.
What conditions does trial NCT05665244 study?
This clinical trial studies the following conditions: Upper-Airway Cough Syndrome.
What interventions are being tested in trial NCT05665244?
The interventions under investigation include: Laryngeal cryotherapy (PROCEDURE), Cryoprobe (DEVICE).
Who is sponsoring clinical trial NCT05665244?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05665244 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.